Institute of Pharmacology and Structural Biology (IPBS), CNRS, UMR5089, University of Toulouse, Toulouse, France.
Mass Spectrometry Core Facility, Institute of Pharmacology and Structural Biology (IPBS), CNRS, UMR5089, University of Toulouse, Toulouse, France.
EMBO Rep. 2020 Nov 5;21(11):e50829. doi: 10.15252/embr.202050829. Epub 2020 Oct 30.
Inflammatory caspase-11 (rodent) and caspases-4/5 (humans) detect the Gram-negative bacterial component LPS within the host cell cytosol, promoting activation of the non-canonical inflammasome. Although non-canonical inflammasome-induced pyroptosis and IL-1-related cytokine release are crucial to mount an efficient immune response against various bacteria, their unrestrained activation drives sepsis. This suggests that cellular components tightly control the threshold level of the non-canonical inflammasome in order to ensure efficient but non-deleterious inflammatory responses. Here, we show that the IFN-inducible protein Irgm2 and the ATG8 family member Gate-16 cooperatively counteract Gram-negative bacteria-induced non-canonical inflammasome activation, both in cultured macrophages and in vivo. Specifically, the Irgm2/Gate-16 axis dampens caspase-11 targeting to intracellular bacteria, which lowers caspase-11-mediated pyroptosis and cytokine release. Deficiency in Irgm2 or Gate16 induces both guanylate binding protein (GBP)-dependent and GBP-independent routes for caspase-11 targeting to intracellular bacteria. Our findings identify molecular effectors that fine-tune bacteria-activated non-canonical inflammasome responses and shed light on the understanding of the immune pathways they control.
炎性半胱天冬酶-11(啮齿动物)和半胱天冬酶-4/5(人类)在宿主细胞胞质中检测革兰氏阴性细菌成分 LPS,促进非经典炎性小体的激活。虽然非经典炎性小体诱导的细胞焦亡和与 IL-1 相关的细胞因子释放对于对抗各种细菌的有效免疫反应至关重要,但它们的不受控制的激活会导致败血症。这表明细胞成分严格控制非经典炎性小体的阈值水平,以确保有效的但非有害的炎症反应。在这里,我们表明干扰素诱导蛋白 Irgm2 和 ATG8 家族成员 Gate-16 协同拮抗培养的巨噬细胞和体内的革兰氏阴性细菌诱导的非经典炎性小体激活。具体而言,Irgm2/Gate-16 轴抑制半胱天冬酶-11 靶向细胞内细菌,从而降低半胱天冬酶-11 介导的细胞焦亡和细胞因子释放。Irgm2 或 Gate16 的缺乏会诱导半胱天冬酶-11 靶向细胞内细菌的 GBP 依赖性和 GBP 非依赖性途径。我们的发现确定了微调细菌激活的非经典炎性小体反应的分子效应物,并阐明了它们控制的免疫途径的理解。